Quantitative bowel apparent diffusion coefficient measurements in children with inflammatory bowel disease are not

T Watson1, A Calder1, J L Barber2

  • 1Department of Radiology, Great Ormond Street Hospital for Children, London, UK.

Clinical Radiology
|March 4, 2018
PubMed

Insights

Quantitative apparent diffusion coefficient (ADC) measurements in pediatric inflammatory bowel disease (IBD) show poor intra-observer and interobserver agreement. These findings suggest current ADC thresholds are unreliable for assessing disease activity in children with IBD.

Area of Science:

  • Radiology
  • Gastroenterology
  • Pediatrics

Background:

  • Quantitative apparent diffusion coefficient (ADC) measurements are used in magnetic resonance imaging (MRI) enterography to assess disease activity in pediatric inflammatory bowel disease (IBD).
  • Variability in ADC measurements can impact diagnostic accuracy and treatment decisions.

Purpose of the Study:

  • To investigate the intra-observer and interobserver variability of quantitative ADC measurements in children with IBD.
  • To determine the reliability of ADC values for characterizing disease activity in pediatric IBD.

Main Methods:

  • Six MRI enterography cases with known active disease were analyzed by nine readers.
  • Readers performed repeat ADC measurements from diseased and unaffected sites at two separate sittings.
  • Statistical analysis included Lin's concordance coefficient and Bland-Altman analysis for intra-observer agreement, and intraclass correlation coefficient (ICC) for interobserver agreement.

Main Results:

  • Seven readers completed the study.
  • Intra-observer agreement for ADC measurements was poor (Lin's coefficient = 0.844).
  • Interobserver variability was poor to moderate (ICC = 0.51), although agreement improved between the two best observers (ICC = 0.85).
  • The observed variability means a single ADC value could correspond to different disease severities, rendering published thresholds unreliable.

Conclusions:

  • Intra-observer and interobserver agreement for quantitative ADC measurements in pediatric IBD is inadequate for accurate disease activity characterization.
  • Current ADC thresholds are not reliable for assessing disease severity in children with IBD.
  • Qualitative assessment of ADC may be a more reliable alternative for evaluating disease activity in this population.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
652
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
743
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
860
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
816